FDA Center for Biologics Evaluation and Research</a> to monitor and evaluate the safety and effectiveness of various vaccines, blood products, and other biologics. For this important public health collaboration, IQVIA worked with the Observational Health Data Science and Informatics initiative and its world-class team of healthcare experts and unique data assets from Columbia University, Stanford University, Georgia Institute of Technology, University of California, Los Angeles and the Regenstrief Institute at the Indiana University School of Medicine to enhance the function and outputs of the initiative.</p> <p><strong>Fighting the Opioid Epidemic:</strong>&nbsp;IQVIA partnered with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" data-gc-link="https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" target="_blank">American Medical Association&rsquo;s Task Force to Reduce Opioid Abuse</a>&nbsp;to help reverse the nation&rsquo;s opioid epidemic and provided valuable insight into the ongoing efforts to combat this public health crisis. Our data and analyses helped illustrate the effects of legislation regarding opioids.</p> <p><strong>Bridging Oncology Gaps:&nbsp;</strong><span>IQVIA has established the Cancer Data Network&nbsp;&ndash; a network that reveals insights that can help our oncology community improve cancer care and patient outcomes, accelerate clinical research and enable innovative contracting. IQVIA is a founding member of <a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.data-can.org.uk/" target="_blank">DATA-CAN</a>, the UK&rsquo;s National Health Data Research Hub, and committed to developing the Cancer Data Network as part of the initiative.</span></p> <p><strong>Addressing Antibiotic Resistance:</strong>&nbsp;IQVIA collaborated with&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" data-gc-link="https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" target="_blank">the U.S. Centers for Disease Control and Prevention</a>&nbsp;and supported White House efforts to combat the overuse and misuse of antibiotics. Information and analysis identified significant regional and local variability in antibiotic use across the United States. The findings shed light on the driving factors behind the rising number of drug-resistant bacteria strains to better inform ongoing prevention efforts.</p> <p><strong>Assessing Disease Burden, Enabling Innovation:</strong>&nbsp;Tuberculosis is a major global public health challenge and India accounts for more than a quarter of these cases on an annual basis. As part of an effort funded by the Bill and Melinda Gates Foundation,<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" data-gc-link="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" target="_blank">&nbsp;IQVIA provided crucial information</a>&nbsp;about tuberculosis managed by the private sector to enable understanding of the true disease burden in the country, and around the world. The work revealed significantly higher rates of tuberculosis than had been previously recognized, as well as prospective causes, which can inform preventative protocols going forward.</p> <p><strong>Malaria Access in Action:</strong>&nbsp;Most malaria-endemic countries lack the ability to monitor the relationship between disease burden and the national supply and quality of critically needed medicines. To address this challenge, we collaborated with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" data-gc-link="https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" target="_blank">Medicines for Malaria</a>&nbsp;Venture to consolidate data flow and enable the Uganda National Drug Authority to complete the development of a system for monitoring pharmaceutical use at a national level.</p> <p><strong>Enabling Alzheimer&rsquo;s Insights:</strong>&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"http://ep-ad.org/" data-gc-link="http://ep-ad.org/" target="_blank">European Prevention of Alzheimer's Dementia (EPAD)</a>&nbsp;is a public-private consortium designed to better understand the early stages of Alzheimer&rsquo;s disease and prevent dementia before symptoms occur. EPAD selected IQVIA to oversee a longitudinal study of 6,000 non-identified patients that enables researchers to track development of Alzheimer&rsquo;s disease symptoms.</p>" /> FDA Center for Biologics Evaluation and Research</a> to monitor and evaluate the safety and effectiveness of various vaccines, blood products, and other biologics. For this important public health collaboration, IQVIA worked with the Observational Health Data Science and Informatics initiative and its world-class team of healthcare experts and unique data assets from Columbia University, Stanford University, Georgia Institute of Technology, University of California, Los Angeles and the Regenstrief Institute at the Indiana University School of Medicine to enhance the function and outputs of the initiative.</p> <p><strong>Fighting the Opioid Epidemic:</strong>&nbsp;IQVIA partnered with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" data-gc-link="https://www.ama-assn.org/sites/default/files/media-browser/public/physicians/patient-care/opioid-task-force-progress-report.pdf" target="_blank">American Medical Association&rsquo;s Task Force to Reduce Opioid Abuse</a>&nbsp;to help reverse the nation&rsquo;s opioid epidemic and provided valuable insight into the ongoing efforts to combat this public health crisis. Our data and analyses helped illustrate the effects of legislation regarding opioids.</p> <p><strong>Bridging Oncology Gaps:&nbsp;</strong><span>IQVIA has established the Cancer Data Network&nbsp;&ndash; a network that reveals insights that can help our oncology community improve cancer care and patient outcomes, accelerate clinical research and enable innovative contracting. IQVIA is a founding member of <a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.data-can.org.uk/" target="_blank">DATA-CAN</a>, the UK&rsquo;s National Health Data Research Hub, and committed to developing the Cancer Data Network as part of the initiative.</span></p> <p><strong>Addressing Antibiotic Resistance:</strong>&nbsp;IQVIA collaborated with&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" data-gc-link="https://www.businesswire.com/news/home/20150602006417/en/IMS-Health-Data-Analytics-Drive-White-House" target="_blank">the U.S. Centers for Disease Control and Prevention</a>&nbsp;and supported White House efforts to combat the overuse and misuse of antibiotics. Information and analysis identified significant regional and local variability in antibiotic use across the United States. The findings shed light on the driving factors behind the rising number of drug-resistant bacteria strains to better inform ongoing prevention efforts.</p> <p><strong>Assessing Disease Burden, Enabling Innovation:</strong>&nbsp;Tuberculosis is a major global public health challenge and India accounts for more than a quarter of these cases on an annual basis. As part of an effort funded by the Bill and Melinda Gates Foundation,<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" data-gc-link="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/abstract" target="_blank">&nbsp;IQVIA provided crucial information</a>&nbsp;about tuberculosis managed by the private sector to enable understanding of the true disease burden in the country, and around the world. The work revealed significantly higher rates of tuberculosis than had been previously recognized, as well as prospective causes, which can inform preventative protocols going forward.</p> <p><strong>Malaria Access in Action:</strong>&nbsp;Most malaria-endemic countries lack the ability to monitor the relationship between disease burden and the national supply and quality of critically needed medicines. To address this challenge, we collaborated with the&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" data-gc-link="https://www.mmv.org/access/products-projects/measuring-pharmaceutical-markets-africa" target="_blank">Medicines for Malaria</a>&nbsp;Venture to consolidate data flow and enable the Uganda National Drug Authority to complete the development of a system for monitoring pharmaceutical use at a national level.</p> <p><strong>Enabling Alzheimer&rsquo;s Insights:</strong>&nbsp;<a rel="noopener noreferrer" href=https://www.iqvia.com/ko-kr/about-us/"http://ep-ad.org/" data-gc-link="http://ep-ad.org/" target="_blank">European Prevention of Alzheimer's Dementia (EPAD)</a>&nbsp;is a public-private consortium designed to better understand the early stages of Alzheimer&rsquo;s disease and prevent dementia before symptoms occur. EPAD selected IQVIA to oversee a longitudinal study of 6,000 non-identified patients that enables researchers to track development of Alzheimer&rsquo;s disease symptoms.</p>" />
Commitment to Global Health

Accelerating global health

We help people live longer, healthier lives by advancing clinical research, delivering healthcare insights, and improving decisions through data, prioritizing impact in regions with limited access to high quality care.

Tackling global health challenges

Combining local expertise and data-driven insights, we develop and implement sustainable solutions tailored to local challenges and opportunities.

Health systems strengthening

We strengthen health systems by combining data, digital innovation, workforce development, and strategic partnerships.

Health security, pandemic preparedness and AMR

We support integrated surveillance and clinical research innovation to respond rapidly to outbreaks and combat antimicrobial resistance.

Health access

We accelerate access to essential and breakthrough medical products through market access expertise, care optimisation strategies, partnerships and policy shaping.

IQVIA Global Health

Our vision for global health

Our vision is to advance healthcare everywhere by transforming data and local insights into scalable and sustainable solutions, delivered with trusted partners globally and in low‑ and middle‑income countries.

Making an impact through collaboration

IQVIA is working with The Global Fund and (RED) to strengthen healthcare in low- and middle-income countries, especially in Africa. Projects like the Data Science Catalytic Fund, launched with Rwanda, aim to drive innovation and speed up disease outbreak response. Through collaboration and technology, IQVIA is helping tackle global health challenges.

About IQVIA’s global health mission

We help people live longer, healthier lives by advancing clinical research, delivering healthcare insights, and improving decisions through data, prioritizing impact in regions with limited access to high quality care.
We combine data science, technology, and healthcare expertise to strengthen health systems and support lifesaving public health initiatives.
IQVIA works across Africa, Asia, Latin America, Europe, North America, and other low- and middle-income regions to expand access and resilience.
We collaborate with governments and health organizations to detect, monitor, and respond to outbreaks using advanced analytics and real-world evidence.
Through partnerships with NGOs, ministries of health, and international agencies, we deliver fast, data-driven strategies to respond to health emergencies.
We apply innovative tools like AI, mobile health apps, and predictive modeling to accelerate clinical research and improve care delivery.
Technology enables faster, more informed decision-making and helps personalize treatments and scale health interventions efficiently.
This joint initiative modernizes public health systems using digital innovation—such as our collaboration with Rwanda to accelerate disease detection.
Our collaborations span governments, NGOs, philanthropic groups, and international organizations with a shared goal of advancing global health.
Contact Us